RSSCategory: Patient Advocacy

Leveraging Technology For Integrated Diagnostic Reporting

| March 9, 2017 | 0 Comments

By Chrystal Adams, Associate Vice President, XIFIN and Don Rule, CEO, Translational Software There is ongoing effort in healthcare to integrate and expand the use of patient data to improve clinical decision making and support cost-effective, patient-centered care. Much of the needed data resides within the diagnostic specialties of pathology, radiology, laboratory, and molecular diagnostics. […]

Continue Reading

Different Sides of the Pond

| February 9, 2017 | 0 Comments

Great story in The Pathologist entitled “An Ocean Apart” — How pathology differs on either side of the Atlantic – and how it doesn’t by Michael Schubert What exactly is a boot? Or a biscuit? Or a chip? If you pictured part of a car, a sweet treat, and a French fry, you may be […]

Continue Reading

Trump Says ACA May Not Be Replaced Until Next Year

| February 6, 2017 | 0 Comments

Politico (2/5, Palmieri) reports that in an interview with Fox News’ Bill O’Reilly which aired before the Super Bowl, President Trump “walked back his recent vow that Obamacare would be replaced in short order,” saying that “the process is ‘complicated’ and ‘maybe it’ll take till sometime into next year.’” Trump said, “It statutorily takes a […]

Continue Reading

To Sign Out or Not to Sign Out? Part 2: The Fax Machine

| January 13, 2017 | 0 Comments

I received a lot of feedback offline about Part 1 of this post (see: “To Sign Out or Not to Sign Out? Part 1” ) from a number of pathologists echoing my sentiments on the issue of turnaround time in general and needs/expectations from clinicians and patients about getting their results in a timely manner. […]

Continue Reading

Mammograms Tied to Over Diagnosis of Breast Cancer

| January 10, 2017 | 0 Comments

This kind of news seems to come up with some regular frequency – “To screen or not to screen, that is the question”. This Danish study recently reported in the Annals of Internal Medicine found that screening was not associated with a lower incidence of advanced tumors and argues that slow-growing, clinically less aggressive tumors may […]

Continue Reading

To Sign Out or Not to Sign Out? Part 1

| December 27, 2016 | 0 Comments

That is the question. Every year. Around the holidays or three-day weekends. Normally biopsies or surgical specimens collected the day before are reviewed the next day. In a majority of cases, the case can be “signed out” meaning your opinion goes into a surgical pathology report and becomes part of the medical record. New malignancies, […]

Continue Reading

Will Cancer Still Be a Surgical Disease in 2027?

| December 25, 2016 | 0 Comments

As we get ready to flip the calendars over to 2017, a year that seems almost made up from the time I was about 10 in 1980 thinking wasn’t even a real number. By now we were supposed to be flying around in our transport pods with flux capacitors, without roads, carrying light sabers perhaps […]

Continue Reading

Patients Protest at Medical Conference

| December 11, 2016 | 0 Comments

It has been said there are only two certainties in life – death and taxes. Actually, there are a few more. The annual ASCO meeting always takes place during the first week of June, the annual RSNA meeting happens the week after Thanksgiving. The annual ASH meeting and the San Antonio Breast Cancer Symposium (SABCS) […]

Continue Reading

FDA Delays Final Guidance on Regulating LDTs

| November 25, 2016 | 0 Comments

medpagetoday.com posted a brief but concise article earlier this week on the issue of FDA regulating laboratory developed tests (LDTs). While the FDA has had the ability to regulate these tests since 1976, largely once regarded as “simple and scarce” as the article mentions, not before a draft guidance issued in 2014 has the FDA […]

Continue Reading

Cancer Moonshot Initiative Grounded

| November 23, 2016 | 0 Comments

Previous posts on this matter referenced that even with the funding proposed in the hundreds of millions dollars (estimated $750 million proposal) a lot more would be required. I believe one critic I referenced said that even with that amount of funding, if approved, wouldn’t “get us off the ground” when it came to this […]

Continue Reading

A cancer patient and pathologist — brought together by Twitter — strike up an unlikely connection

| October 27, 2016 | 0 Comments

Courtesy of STAT  By Linnea Olson and Michael Misialek Awesome read about a patient and pathologist exploring lung cancer together. Patients can be their own best advocates while pathologists should have the opportunity to meet their patients. While every surgical pathology accession number is a life, putting a face with a name can be mutually beneficial. […]

Continue Reading

Jessica and a Weekend in California

| October 20, 2016 | 0 Comments

Jessica is a 42-year old wife and mother of 2. She was diagnosed with an aggressive form of breast cancer just over seven years ago and doctors recently declared her with no evidence of disease. As a young woman with breast cancer, she became affiliated with the Young Survival Coalition (YSC) and this year completed […]

Continue Reading

Study Questions Value of Routine Mammograms

| October 13, 2016 | 0 Comments

A recent news brief service recently sent out highlights about a new study published in NEJM that questions the value of mammography for breast cancer screening while critics cited in the news brief call the study “deeply flawed” and suggest keeping with the recommendations. The study was conducted by researchers at Dartmouth and NCI and […]

Continue Reading

Pink Cleats Will Not Cure Cancer

| October 5, 2016 | 0 Comments

Last Friday was the end of the month, end of the quarter, and for some companies and organizations, end of the fiscal year. October, as it used to be called, as in “Mr. October”, would strike at Midnight on Saturday as Pinktober for 31 days, ending in a holiday characterized by black and orange and […]

Continue Reading